Skip to content

The PERFusion Use in Stroke Evaluation Study

Expanding the Time Window for IV Thrombolysis With Rt-PA in Acute Ischemic Stroke Patients Using Computed Tomography Perfusion Imaging: The PERFusion Use in Stroke Evaluation (PERFUSE) Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01387113
Acronym
PERFUSE
Enrollment
48
Registered
2011-07-04
Start date
2011-05-31
Completion date
2022-07-31
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Keywords

stroke, tPA, Thrombolysis, rt-PA, Ischemic, CTP, Imaging, CT Perfusion Imaging, Perfusion, CTA, CT Angiography, Acute ischemic stroke, Acute stroke therapy, (AIS)

Brief summary

This is an open label single center phase II trial, evaluating the utility of 64 slice CT perfusion (CTP) in acute ischemic stroke (AIS) patients. The main aim is to determine which aspects of CTP imaging can aid in expanding the time window for thrombolysis with IV (rt-PA) in AIS patients up to 6 hours after symptom onset.

Interventions

As per standard of care at CPMC

Sponsors

California Pacific Medical Center
CollaboratorOTHER
California Pacific Medical Center Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute ischemic stroke * ≥ 18 years old * presentation up to 6 hours from time of onset of acute stroke symptoms

Exclusion criteria

* pregnancy * inability to receive CT scan * allergy to IV contrast * symptoms with full resolution * intracerebral hemorrhage * severe stroke which is classified as 'malignant' (hypodensity on noncontrast CT greater than 1/3 cerebral hemisphere) * premorbid mRS of \>3 * life expectancy of ≤3 months * any condition which, in the opinion of the investigator makes the subject unsuitable for study

Design outcomes

Primary

MeasureTime frame
Final infarct volume24 hour post-thrombolysis

Secondary

MeasureTime frame
Large vessel occlusion on neuroimaging24 hours post-thrombolysis
NIHSS24-hours from tPA adminsitration
Symptomatic intracerebral hemorrhage post-thrombolysis24 hours post-thrombolysis
Modified Rankin Scale3-months from tPA administration

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026